Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Depreciation and Depletion (2023 - 2025)

Mangoceuticals' Depreciation and Depletion history spans 3 years, with the latest figure at $255.0 for Q3 2025.

  • For Q3 2025, Depreciation and Depletion rose 1.19% year-over-year to $255.0; the TTM value through Sep 2025 reached $1012.0, down 93.66%, while the annual FY2024 figure was $9936.0, 60.08% down from the prior year.
  • Depreciation and Depletion for Q3 2025 was $255.0 at Mangoceuticals, up from $252.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $6292.0 in Q3 2023 and bottomed at $250.0 in Q1 2025.
  • The 3-year median for Depreciation and Depletion is $3205.0 (2024), against an average of $3234.7.
  • The largest YoY upside for Depreciation and Depletion was 2.33% in 2024 against a maximum downside of 95.99% in 2024.
  • A 3-year view of Depreciation and Depletion shows it stood at $6291.0 in 2023, then tumbled by 95.95% to $255.0 in 2024, then changed by 0.0% to $255.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Depreciation and Depletion are $255.0 (Q3 2025), $252.0 (Q2 2025), and $250.0 (Q1 2025).